Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tian An MedicareCOLRF 43 Debt-to-EBITDA is -33.25 as of Dec. 2025. GuruFocus rates COLRF with a GF Score™ of 43/100 and a GF Value™ of $0.07. The stock has 4 warning signs investors should review. Among 477 Healthcare Providers & Services companies, Tian An Medicare ranks worse than 98.74% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Tian An Medicare's Debt-to-EBITDA or its related term are showing as below:
COLRF'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -5 Med: 11.56 Max: 40.75
Current: 40.75
During the past 13 years, the highest Debt-to-EBITDA Ratio of Tian An Medicare was 40.75. The lowest was -5.00. And the median was 11.56.
COLRF's Debt-to-EBITDA is ranked worse than 98.74% of 477
companies
in the Healthcare Providers & Services industry
Industry Median: 2.22
vs COLRF: 40.75
Tian An Medicare (OTCPK:COLRF) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Tian An Medicare Debt-to-EBITDA Related Terms
Tian An Medicare Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Tian An Medicare's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Tian An Medicare's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tian An Medicare Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Tian An Medicare's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Tian An Medicare's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is two times the quarterly (Dec. 2025) EBITDA data.
Tian An Medicare (COLRF) has a Debt-to-EBITDA of -33.25 as of Dec. 2025. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Tian An Medicare. According to the industry distribution chart, Tian An Medicare ranks #471 out of 477 companies in the Healthcare Providers & Services industry, placing it in the top 98.7%.
Is Tian An Medicare's Debt-to-EBITDA too high?
Tian An Medicare's current Debt-to-EBITDA is -33.25. Based on the distribution chart, Tian An Medicare ranks #471 out of 477 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Tian An Medicare has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Tian An Medicare's Debt-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Tian An Medicare ranks #471 out of 477 companies for Debt-to-EBITDA. This places Tian An Medicare in the lower half of its industry. The industry median Debt-to-EBITDA is 2.22. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.22, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Tian An Medicare. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tian An Medicare's current Debt-to-EBITDA is -33.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tian An Medicare stock overvalued right now?
Tian An Medicare (COLRF) has a current Debt-to-EBITDA of -33.25. The stock's GF Value™ is $0.07, compared to a current price of $0.08 — trading 14.3% above its estimated fair value. The current Debt-to-EBITDA is -33.25. Tian An Medicare's overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Tian An Medicare (COLRF), the current Debt-to-EBITDA is -33.25 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tian An Medicare (COLRF) Overvalued in 2026?
Based on GuruFocus' analysis, Tian An Medicare stock appears to be overvalued.
The current stock price of $0.08 is trading 14.3% above its estimated GF Value™ of $0.07.
Key valuation signals for COLRF:
Debt-to-EBITDA: -33.25
GF Value™: $0.07 vs. price of $0.08 (14.3% above fair value)
No single metric tells the full story. See the COLRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tian An Medicare Ltd is an investment holding company and operator of integrated healthcare and eldercare services. Its main focus is on the investment, management and operations of healthcare and eldercare businesses, and the related property investment and development, and comprehensive spectrum of healthcare and eldercare services to customers in the People's Republic of China (PRC) and Asia Pacific. The Group is also involved in businesses of securities trading and investment, and provision of financial services. Its segments includes: Healthcare; Eldercare; and Property Development, of which it derives maximum revenue from Healthcare segment.
43GF Score
Get the complete analysis for COLRF
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COLRF has been successfully added to your 
